Looking to list your PhD opportunities? Log in here.
About the Project
Funding received from the Medical Research Council, Royal Society, Sasakawa Foundation, Commonwealth Scholarship Commission, National Institute of Health Research and a number of venture capital companies enabled us to investigate the consequences of gene defects and screened thousands of compounds including established drugs and natural products. The prospective student will investigate how dysfunctional BMP and TGFβ signalling pathways contribute to disease pathogenesis and identify novel therapeutic intervention using natural products. The project will introduce the student to the broader areas of molecular genetics, biochemistry, drug discovery, pharmacology and translational medicine.
The research activities will be undertaken at the School of Pharmacy and Medical Sciences, University of Bradford. The studies will be performed in the recently renovated laboratories provided with state of the art equipments including high-throughput fluorescence and luminescence plate readers, QPCR machines, gel doc systems and modern tissue culture facilities. The research sits in the context of a highly active research environment at the University of Bradford.
Email Now
Why not add a message here
The information you submit to University of Bradford will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.

Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Bradford, United Kingdom
Check out our other PhDs in United Kingdom
Start a New search with our database of over 4,000 PhDs

PhD suggestions
Based on your current search criteria we thought you might be interested in these.
Therapeutic resolution of BMPR2-mediated signalling defects in pulmonary arterial hypertension (PAH)
University of Bradford
Re-purposing established drugs for the resolution of pulmonary arterial hypertension (PAH)
University of Bradford
Therapeutic resolution of Myelodysplastic Syndrome (MDS) by natural products
University of Bradford